13 results on '"Arizon, J"'
Search Results
2. 332: The Slope of Renal Function in De Novo HTxR. Can We Improve?
3. 695: Rapid Achievement of Therapeutic Levels and Exposure-Efficacy Analysis in De Novo Cardiac Transplant Recipients on Everolimus-Based Immunosuppression
4. 466: Hospitalization Days Due to Major Cardiac Events (MACE) in De Novo Heart Transplant Recipients: Data from a 12-Month, Multicenter, Randomized Trial of Everolimus Versus MMF
5. 161: Impact of De Novo Everolimus-Based Immunosuppression on Wound Healing and Tissue Regeneration in Heart Transplantation
6. 299: Comparability of Pattern of Occurrence of Pericardial Effusions between Everolimus- and MMF-Based Regimen in De Novo Cardiac Transplant Recipients
7. 15: Results of a 12-Month, Multicenter, Randomized Trial of Everolimus with Reduced-Exposure Cyclosporine Versus MMF and Standard-Exposure Cyclosporine in De Novo Cardiac Transplant Recipients
8. A 12-month, multicenter, randomized, adaptive design, open-label study to evaluate the benefit of C2-hr monitoring of Neoral on safety and efficacy outcomes in de novo cardiac transplant recipients receiving basiliximab induction: 6-month outcomes
9. 14–Base pair polymorphism of human leukocyte antigen–G as genetic determinant in heart transplantation and cyclosporine therapy monitoring
10. A 12-month, multicenter, randomized, adaptive design, open-label study to evaluate the benefit of C2 hour monitoring of neoral on safety and efficacy outcomes in de novo cardiac transplant recipients receiving basiliximab induction
11. 245 Wound Healing Events and Effusions with Everolimus Versus MMF Based Regimens in De Novo Heart Transplant Recipients
12. 397: Everolimus with reduced cyclosporine exposure vs. MMF and conventional cyclosporine: Results from a study in de novo heart transplant recipients
13. Everolimus in de novo cardiac transplant recipients: 48-month (M) follow-up
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.